A group including KKR (KKR) and Warburg Pincus has submitted a non-binding offer for Gerresheimer AG (GRRMF), which makes pens used to inject weight loss drugs such as Wegovy, Reuters’ Emma-Victoria Farr and Anirben Sen report, citing two people with knowledge of the matter. The consortium has made an offer of nearly EUR 90 per share, which would value the company at approximately EUR 3.1B, the authors note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KKR:
- KKR & Co Appoints Timothy Barakett to Board
- U.S. Supreme Court refused to revive $1.6B award against IBM, Bloomberg says
- M&A News: KKR Stock Sickens as it Makes Sweetened $2B Offer for U.K. Healthcare Group Assura
- KKR price target lowered to $183 from $189 at TD Cowen
- KKR put volume heavy and directionally bearish
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue